Mkts

PTC Therapeutics, Inc.

NASDAQ: PTCT
$59.38-0.85 (-1.41%)
As of Nov 19, 9:30 AM ET

Key statistics

Day range
59.1860.70
52-week range
58.8090.87
Today
Open60.67
Previous close59.38
Volume12.9K
Valuation
Market cap5.47B
P/E ratio—
EPS (TTM)-1.39
Income & risk
Dividend / yield—
Beta0.48
Avg volume666.2K
Discussion

PTCT News

Stories mentioning PTCT from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue272,551164,677211,007178,8751,176,096213,172196,786186,704
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development100,873133,128100,158112,990108,973124,770161,412132,169
Sales General & Admin86,18396,87484,04685,26280,96184,68373,45669,500
Total Operating Expenses227,592236,026207,991213,832205,871375,561251,296226,922
Operating Income (Loss)44,959(71,349)3,016(34,957)970,225(162,389)(54,510)(40,218)
Interest Income
Interest Expense
Other Expense1,609(12,546)6,502(5,737)(6,305)8,850(1,872)(2,025)
Pretax Income(2,462)(139,083)(23,074)(71,052)929,828(94,699)(97,991)(85,733)
Tax Provision347.00(4,118)(38,970)(6,203)63,266(28,813)8,66313,446
Net Income (Loss)(2,809)(134,965)15,896(64,849)866,562(65,886)(106,654)(99,179)
Earnings Per Share (Basic)(0.03)(1.70)0.20(0.83)11.09(0.86)(1.39)(1.29)
Earnings Per Share (Diluted)(0.03)(1.53)0.20(0.83)10.04(0.86)(1.39)(1.29)
Weighted Average Shares Outstanding (Basic)82,52179,53478,47178,15178,11676,84576,92676,725
Weighted Average Shares Outstanding (Diluted)82,52188,31187,11578,15186,38676,84576,92676,725

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About PTCT

PTC Therapeutics, Inc. (NASDAQ: PTCT) is a stock listed on the Nasdaq Stock Market under the ticker symbol PTCT. It last traded at $59.38 (Nov 19, 2026, 9:30 AM ET), down 1.4% on the day. That gives PTC Therapeutics a market capitalisation of $5.5B.

Over the past 52 weeks PTCT has traded between $58.80 and $90.87.

Revenue for the quarter ended Mar 31, 2026 was $272.6M; a net loss of $2.8M. Revenue was down 76.8% from $1.2B in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$272.6M-$2.8M-1.0%
Dec 31, 2025$164.7M-$135.0M-82.0%
Sep 30, 2025$211.0M$15.9M7.5%
Jun 30, 2025$178.9M-$64.8M-36.3%

From PTC Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…